Genworth Financial INC
Market Movers (8-K)
NYSE
Genworth Financial announced its President & CEO, Thomas J. McInerney, is taking a temporary leave of absence for health reasons, with CFO Jerome Upton appointed as interim CEO.
NYSE
Genworth Financial's 2026 annual meeting saw the election of all director nominees, approval of executive compensation, a stock purchase plan, and auditor ratification.
NYSE
Genworth Financial reports $47 million net income for Q1 2026, driven by strong performance from Enact and continued investment in CareScout.
NYSE
Genworth Financial reports mixed Q4 2025 results with strong performance from its Enact mortgage insurance segment offset by significant losses in its Closed Block long-term care insurance.
Capital raise
Worse than expected
NYSE
Genworth Financial, Inc. announced its fourth-quarter 2025 earnings release date and conference call, following its subsidiary Enact Holdings, Inc.'s financial results announcement.
NYSE
Genworth Financial reports mixed third-quarter 2025 results, driven by strong net income and strategic CareScout expansion, but offset by a significant increase in long-term care operating losses.
Worse than expected
Quarterly Earnings (10-Q)
NYSE
Genworth Financial reported a decrease in net income available to common stockholders for Q1 2026, impacted by market fluctuations and strategic investments, though its Enact segment showed operational strength.
Worse than expected
NYSE
Genworth Financial reports increased net income for Q3 2025 but a decline in adjusted operating income, while making significant strides in its CareScout growth initiatives and share repurchase program.
Worse than expected
Delay expected
NYSE
Genworth Financial, Inc. reported a significant decrease in net income and adjusted operating income for the second quarter and first half of 2025, primarily driven by challenges in its legacy insurance segments, despite ongoing strategic investments and strong capital positions in its mortgage insurance business.
Delay expected
Worse than expected
NYSE
Genworth Financial's Q1 2025 results show a net income of $54 million, influenced by various factors across its Enact, Long-Term Care Insurance, and Life and Annuities segments.
Worse than expected
NYSE
Genworth Financial's Q3 2024 results show a complex picture with some segments performing well while others face challenges, amidst a backdrop of market fluctuations.
NYSE
Genworth Financial's second quarter 2024 results show a net income of $76 million, influenced by investment losses and reserve adjustments, while adjusted operating income reached $125 million.
Worse than expected
Annual Reports (10-K)
NYSE
Genworth Financial's 2025 Annual Report highlights a strategic pivot to CareScout for growth, continued capital returns from Enact, and ongoing management of its Closed Block legacy insurance products.
Worse than expected
Delay expected
NYSE
Genworth Financial files its annual report on Form 10-K, detailing its financial performance and strategic priorities for the fiscal year ended December 31, 2024.
NYSE
Genworth Financial has established a split-dollar life insurance plan to provide death benefit protection and potential cash value accumulation for selected key employees.
Delay expected
Insider Trading (Form 4)
NYSE
Samir B. Shah, Pres. & CEO, CareScout of Genworth Financial Inc, reported multiple transactions in common stock on July 13, 2026.
NYSE
Genworth Financial CEO Thomas J. McInerney reported a charitable gift of 200,000 shares of common stock.
NYSE
Thomas J. McInerney, President and CEO of Genworth Financial Inc., reported a transaction involving the sale of 100,000 shares of common stock.
NYSE
Robert P. Restrepo Jr., a Director at Genworth Financial Inc., reported a sale of 50,000 shares of common stock on May 22, 2026.
NYSE
Director Steven C. Van Wyk acquired 32,100 restricted stock units as part of his annual retainer fee for Genworth Financial Inc.
NYSE
Genworth Financial director Ramsey D. Smith received 18,264 restricted stock units as part of his annual retainer fee, increasing his total holdings to over 92,000 shares.
Proxy Statements (Def-14A)
NYSE
Genworth Financial has filed definitive additional proxy soliciting materials with the SEC.
NYSE
DEFC14A: Genworth Financial Highlights 2024 Achievements and Strategic Priorities in Proxy Statement
Genworth Financial's 2025 proxy statement highlights the company's 2024 performance, strategic achievements, and key governance practices, emphasizing shareholder value and long-term care solutions.
Better than expected
NYSE
Genworth Financial's upcoming annual meeting on May 23, 2024, will include voting on the election of directors, executive compensation, auditor ratification, and amendments to the company's certificate of incorporation.
NYSE
Genworth Financial is seeking stockholder approval to amend its certificate of incorporation, removing legacy GE provisions and updating special meeting rights.
Institutional Holdings (13F)
NYSE
Genworth Financial Inc reported 2 holdings worth $486.1M for the period ended June 30, 2026.
NYSE
Genworth Financial Inc. reported its Q1 2026 13F holdings, detailing significant investments in S&P 500-related ETFs.
NYSE
Genworth Financial Inc. has filed its Form 13F-HR, revealing its investment portfolio as of December 31, 2025, totaling $445.8 million across two major ETF holdings.
NYSE
Genworth Financial Inc. reported its third-quarter 2025 equity holdings, totaling $437.2 million across two S&P 500-focused ETFs.
NYSE
Genworth Financial Inc. has filed its quarterly Form 13F-HR, revealing its equity holdings for the quarter ended June 30, 2025, totaling over $407 million across two major ETF positions.
NYSE
Genworth Financial Inc. reports its Q1 2025 holdings, with significant investments in Powershares S&P 500 Low Volatility and iShares Core S&P 500 Index ETF.
Schedule 13G - Passive Investments
NYSE
Donald Smith & Co., Inc. and DSCO Value Fund, L.P. have reported beneficial ownership of 6.6% of Genworth Financial Inc.'s common stock as of March 31, 2026.
NYSE
Vanguard Capital Management has filed a Schedule 13G reporting a 5.4% beneficial ownership stake in Genworth Financial Inc.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 6.13% in Genworth Financial Inc. common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in Genworth Financial Inc. following an internal realignment.
Worse than expected
NYSE
Donald Smith & Co., Inc. and DSCO Value Fund, L.P. have reported a combined 5.95% beneficial ownership stake in Genworth Financial Inc. as of December 31, 2025.
NYSE
Investment adviser Donald Smith & Co., Inc. and DSCO Value Fund, L.P. have disclosed a combined 6.09% beneficial ownership stake in Genworth Financial Inc.